临床外科杂志 ›› 2026, Vol. 34 ›› Issue (5): 513-517.doi: 10.3969/j.issn.1005-6483.20241907

• 论著 • 上一篇    下一篇

手术标本磷脂酶Cε1 mRNA、Src同源结构域3蛋白1 mRNA、细胞周期蛋白依赖性激酶12 mRNA联合预测胃癌内镜黏膜下剥离术后早期病情进展的增益价值

  

  1. 610000  四川成都,成都市双流区第一人民医院普外科
  • 收稿日期:2024-12-02 接受日期:2024-12-02 出版日期:2026-05-20 发布日期:2026-05-20
  • 通讯作者: 张雅军,Email:zyj228065@163.com
  • 基金资助:
    2020年四川省医学(青年医学)科研课题项目(Q20131)

The gain value of phospholipase C ε1 mRNA,Src homology domain 3 protein 1  mRNA,and cyclin-dependent kinase 12 mRNA in surgical specimens combined to predict early disease progression after endoscopic submucosal dissection for gastric cancer

  1. Department of General Surgery,The First People's Hospital of Shuangliu District,Chengdu 610000,China
  • Received:2024-12-02 Accepted:2024-12-02 Online:2026-05-20 Published:2026-05-20

摘要: 目的 研究手术标本磷脂酶Cε1(PLCE1) mRNA、Src同源结构域3蛋白1(LASP1) mRNA、细胞周期蛋白依赖性激酶12(CDK12) mRNA表达联合预测胃癌内镜黏膜下剥离术(ESD)术后早期病情进展的增益价值。方法 2021年1月~2023年5月诊断为胃癌行ESD术的病人184例,根据术后1年病情是否进展分为两组,其中病情进展26例(病情进展组),病情未进展158例(非病情进展组)。采用实时荧光定量PCR法检测两组癌组织和癌旁组织(距离肿瘤病灶2cm)PLCE1 mRNA、LASP1 mRNA、CDK12 mRNA。采用多因素Logistic回归分析PLCE1、LASP1、CDK12基因表达对胃癌ESD术后早期病情进展的影响,以受试者工作特征(ROC)曲线分析PLCE1 mRNA、LASP1 mRNA、CDK12 mRNA及联合预测胃癌ESD术后早期病情进展价值。结果 病情进展组浸润程度为浅层黏膜下、合并存在溃疡占比高于非病情进展组,差异有统计学意义(P<0.05);两组癌组织PLCE1 mRNA、LASP1 mRNA、CDK12 mRNA高于癌旁组织,差异有统计学意义(P<0.05);病情进展组癌组织PLCE1 mRNA、LASP1 mRNA、CDK12 mRNA高于非病情进展组,差异有统计学意义(P<0.05);多因素分析显示,PLCE1 mRNA升高、LASP1 mRNA升高、CDK12 mRNA升高是胃癌ESD术后早期病情进展的独立相关影响因素(P<0.001),三者每升高1个单位,术后早期病情进展的风险提高1.318、1.226、1.352倍;ROC曲线分析结果显示,PLCE1 mRNA、LASP1 mRNA、CDK12 mRNA预测胃癌ESD术后早期病情进展的AUC分别为0.815、0.750、0.792,PLCE1 mRNA+LASP1 mRNA+CDK12 mRNA预测胃癌ESD术后早期病情进展的AUC为0.935(95%CI:0.889~0.966),高于PLCE1 mRNA(Z=2.816,P=0.041),联合预测的敏感度为92.31%,特异度为85.44%。结论 手术标本PLCE1、LASP1、CDK12基因表达均与胃癌ESD术后早期病情进展独立相关,联合检测三者能提高对胃癌ESD术后早期病情进展的预测价值。

关键词: 磷脂酶Cε1 mRNA, Src同源结构域3蛋白1 mRNA, 细胞周期蛋白依赖性激酶12 mRNA, 基因;胃癌;ESD;术后早期病情进展;预测效能

Abstract: Objective To investigate the gain value of the combined expression of phospholipase C ε1 (PLCE1) mRNA,Src homology domain 3 protein 1 (LASP1) mRNA,and cyclindependent kinase 12 (CDK12) mRNA in predicting early disease progression after endoscopic submucosal dissection (ESD) for gastric cancer.Methods The clinical data of 184 patients diagnosed with gastric cancer in our hospital from January 2021 to May 2023 who underwent ESD surgery were retrospectively analyzed,Patients were divided into disease progression group(26 cases) and non-disease progression group(158 cases) according to whether their condition progressed one year after surgery.Real-time fluorescence quantitative PCR was used to detect and compare PLCE1 mRNA,LASP1 mRNA,and CDK12 mRNA in cancer tissues and paracancer tissues (2 cm away from the tumor lesions) of the two groups.The impact of PLCE1,LASP1,and CDK12 gene expression on early disease progression after ESD in gastric cancer was analyzed using a Multivariate logistic regression equation.The value of PLCE1 mRNA,LASP1 mRNA,CDK12 mRNA,and their combined prediction for early disease progression after ESD of gastric cancer was analyzed using receiver operating characteristic (ROC) curve analysis.Results The proportion of patients with superficial submucosal infiltration and ulceration in the disease progression group was higher than that in the non-disease progression group (P<0.05).The levels of PLCE1 mRNA,LASP1 mRNA,and CDK12 mRNA in the cancer tissues of both groups were higher than those in the tissues adjacent to the cancer (P<0.05).The levels of PLCE1 mRNA,LASP1 mRNA,and CDK12 mRNA in cancer tissues from the disease progression group were higher than those in the non-disease progression group (P<0.05).Multivariate analysis showed that the increase in PLCE1 mRNA,LASP1 mRNA,and CDK12 mRNA were independent factors associated with early disease progression after ESD in gastric cancer (P<0.001).Each increase of 1 unit in these three factors increased the risk of early disease progression by 1.318,1.226,and 1.352 times,respectively.In ROC analysis,the AUCs of PLCE1 mRNA,LASP1 mRNA,and CDK12 mRNA for predicting early disease progression after ESD in gastric cancer were 0.815,0.750,and 0.792,respectively.The AUC of PLCE1 mRNA + LASP1 mRNA + CDK12 mRNA for predicting early disease progression after ESD in gastric cancer was 0.935 (95%CI:0.889~0.966),which was higher than that of PLCE1 mRNA (Z=2.816,P=0.041).The sensitivity of combined prediction was 92.31%,and the specificity was 85.44%.Conclusion The gene expression of PLCE1,LASP1,and CDK12 in surgical specimens is independently associated with early disease progression after ESD of gastric cancer.Combined detection of the three genes can improve the gain value of early disease progression after ESD of gastric cancer.

Key words: PLCE1, LASP1, CDK12, gene, gastric cancer, endoscopic submucosal dissection, early disease progression after operation, predictive effectiveness

No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 宫念樵. 器官捐献供肾质量评估[J]. 临床外科杂志, 2016, 24(10): 729 .
[2] 林俊. 原发性中枢神经系统恶性肿瘤供者在器官移植中的应用[J]. 临床外科杂志, 2016, 24(10): 737 .
[3] 石宇;刘学刚 . 冠状动脉旁路移植术后短期内应用强化他汀对患者出血风险的研究[J]. 临床外科杂志, 2016, 24(10): 750 .
[4] 陈忠;王耀东;田毅峰;等. 肝胆管结石病规范化治疗的临床分析[J]. 临床外科杂志, 2016, 24(10): 753 .
[5] 江帆;孙权;吴国俊;等. 不同引流方式对恶性梗阻性黄疸患者细胞免疫的影响[J]. 临床外科杂志, 2016, 24(10): 760 .
[6] 李光焰;张安平;王祥峰;等. 直肠癌切除术后吻合口狭窄14例分析[J]. 临床外科杂志, 2016, 24(10): 772 .
[7] 张忠伟;刘扬;路明. 痔上黏膜环切术治疗直肠前突所致出口梗阻型便秘的疗效观察[J]. 临床外科杂志, 2016, 24(10): 774 .
[8] 肖国栋;刘国辉. 跗骨窦切口联合经皮置钉技术微创治疗跟骨骨折的临床疗效分析[J]. 临床外科杂志, 2016, 24(10): 783 .
[9] 刘琼;江辉. 喉罩在小儿舌系带矫正手术中的应用[J]. 临床外科杂志, 2016, 24(10): 792 .
[10] 胡光俊;宋晓阳;陶军. 右美托咪定添加到罗哌卡因中对腰丛坐骨神经阻滞及镇静的影响[J]. 临床外科杂志, 2016, 24(10): 796 .